CD4 and cancer: In the T1D sphere, HIPs were reported as T cell epitopes (25) before spliced peptides were (24); however, spliced peptides as epitopes for CD8+ T cells in cancer immunology were discovered over a decade before HIPs were described as CD4+ T cell targets (55, 57).